pharma · Peripheral Artery Disease · Muscle-Invasive Bladder Carcinoma
Blackmores Institute
Blackmores Limited
Blackmores Institute trial registry — 18 ClinicalTrials.gov studies with program phase, status, and indication context.
20 Jubilee Ave, Warriewood, New South Wales 2102, AU HQ
2012 Founded
27 Employees
TGA registrant Type
Company details
- Status
- Public
- HQ
- 20 Jubilee Ave, Warriewood, New South Wales 2102, AU
- Founded
- 2012
- Employees
- 27
- Programs
- 17
- Drugs
- 24
- Patents
- 38
Blackmores Institute clinical trials
Registry index of 18 ClinicalTrials.gov studies linked to Blackmores Institute programs — each row shows trial ID, program name, phase, status, and indication.
Blackmores Institute trial registry — 18 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Blackmores Institute.
-
ZKSJ0132 — Unknown
Clinical update -
GARM-Autism Adults — Phase 2
Clinical update -
silevertinib in combination with temozolomide — Phase 2
Clinical update -
Normal Saline (NS) .9% 10 mL Injection — Phase 1
Clinical update -
Liposomal bupivacaine — Approved
Clinical update -
Levodopa — Phase 1
Clinical update -
Azathioprine 50Mg Tab — Phase 1
Clinical update -
Percutaneous Transluminal Angioplasty (PTA) — Unknown
Clinical update